Skip to content

Clinical trials

Generalized Anxiety Disorder trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Country / region: China Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20161
20171
20181
20221
20235
20242
20252
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Not yet recruiting6
Recruiting6
Completed5
Unknown status3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Union Pharmaceutical Factory Ltd3
Anhui Medical University2
Shanghai Mental Health Center2
Beijing Tongren Hospital1
Central South University1
Eli Lilly and Company1
Fudan University1
Lin Xiaoqian1
Luye Pharma Group Ltd.1
Marubeni Pharmaceuticals (Suzhou) Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder21
Major Depressive Disorder3
Anxiety Disorders1
Breast Neoplasms1
Cognitive Dysfunction1
Depressive Disorder1
Obsessive-Compulsive Disorder1
Panic Disorder1
Phobia, Social1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.